跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Sanofi Winthrop Industrie
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 13, 2024
Approval ID
c47ccf58c5f4a926
Company
Sanofi Winthrop Industrie
Type
Standard
Approval Details
Approval Id
c47ccf58c5f4a926
Drug Cima Aemps Name
APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
97046027IP1
Holder Company Name
Sanofi Winthrop Industrie
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/sanofi-winthrop-industrie
Authorization Date
2024-02-13
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
300 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sanofi Winthrop Industrie
Company Detail Path
/organization/sanofi-winthrop-industrie
Company Information
Pharmaceutical Company Name
SANOFI WINTHROP INDUSTRIE
Country Name
France
City Name
amilly,centre val de loire,country_fr
Address
130 RUE DE LA FONTAINE
Active Ingredients
IRBESARTAN
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 13, 2024
Approval ID
c47ccf58c5f4a926
Type
Standard
Back to CIMA-AEMPS Approvals
